Page 19 - Pascal Deschatelets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Asymmetry Capital Management L.P. acquired a new position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 139,445 shares of the company’s stock, valued at approximately $6,593,000. Apellis Pharmaceuticals makes up about 3.5% of Asymmetry Capital Management L.P.’s holdings, making the stock its 14th largest […]

"The situation with the cost of living is extremely difficult for everyone," says Dominique Anglade, who also wants to stop taxing a number of essential goods.

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) – Wedbush lifted their Q1 2022 earnings per share (EPS) estimates for Apellis Pharmaceuticals in a research report issued on Tuesday, March 1st. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($1.09) for the quarter, up from their prior forecast of […]

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating)’s share price traded up 7% during trading on Tuesday after Raymond James raised their price target on the stock from $112.00 to $114.00. Raymond James currently has a strong-buy rating on the stock. Apellis Pharmaceuticals traded as high as $45.74 and last traded at $45.50. 41,646 shares were […]